FindTrial
Sign In

Serum metabolomics study for radioiodine refractory differentiated thyroid carcinoma

Serum metabolomics study for radioiodine refractory differentiated thyroid carcinoma

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800020376
Enrollment
Unknown
Registered
2018-12-27
Start date
2019-01-01
Completion date
Unknown
Last updated
2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

thyroid carcinoma

Interventions

Distant metastasis-radioiodine refractory:N/A
Distant metastasis-non radioiodine refractory:N/A

Sponsors

Shanghai Jiao Tong University Affiliated Sixth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Clinical diagnosis of radioiodine refractory differentiated thyroid carcinoma

Exclusion criteria

Exclusion criteria: Other malignancy history; History of diabetes,hypertension,hyperlipemia.

Design outcomes

Primary

MeasureTime frame
serum metabolites;—

Countries

China

Contacts

Public ContactChentian Shen

Shanghai Jiao Tong University Affiliated Sixth People's Hospital

shenchentian@126.com+86 15216616515

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026